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a b s t r a c t
Intestinal damage in malnutrition constitutes a threat to the survival of many thousands of children globally. We
studied children in Lusaka, Zambia, with severe acute malnutrition (SAM) and persistent diarrhea using endoscopy, biopsy and analysis of markers and protective proteins in blood and intestinal secretions. We carried out
parallel investigations in apparently healthy adults, and analyzed biomarkers only in apparently healthy children.
Villus height and crypt depth did not differ in children with SAM and adult controls, but epithelial surface was
reduced in children with SAM (median 445, interquartile range (IQR) 388, 562 μm per 100 μm muscularis mucosae) compared to adults (578, IQR 465,709; P = 0.004). Histological lesions and disruptions of claudin-4 and Ecadherin were most pronounced in children with SAM. Circulating lipopolysaccharide, a marker of bacterial
translocation, was higher in malnourished children (251, IQR 110,460 EU/ml) than in healthy children (51, IQR
0,111; P = 0.0001). Other translocation markers showed similar patterns. Anti-Deamidated Gliadin Peptide
IgG concentrations, although within the normal range, were higher in children with SAM (median 2.7 U/ml,
IQR 1.5–8.6) than in adults (1.6, 1.4–2.1; P = 0.005), and were inversely correlated with villus height (ρ =
−0.79, n = 13, P = 0.001). Malnutrition enteropathy is associated with intestinal barrier failure and immune
dysregulation.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).

1. Introduction
Malnutrition underlies 45% of child deaths in low- and middle-income countries (LMICs) (McDonald et al., 2013). Severe acute malnutrition (SAM) is characterized by low weight for height (wasting), with or
without edema, and affects approximately 20 million children annually.
While community management of acute malnutrition has transformed
outcomes for children with uncomplicated SAM (Amadi et al., 2016;
Collins et al., 2006), children with medical complications such as acute
infections still require hospitalization. Despite standardized treatment
protocols, inpatient SAM case fatality rates remain 10–30% (Ahmed et
al., 1999; Attia et al., 2016; Tickell and Denno, 2016), and are even
⁎ Corresponding author at: Blizard Institute, Barts & The London School of Medicine,
Queen Mary University of London, 4 Newark Street, London E1 2AT, UK.
E-mail address: m.p.kelly@qmul.ac.uk (P. Kelly).

higher among those with HIV infection (Kerac et al., 2014; Fergusson
and Tomkins, 2009).
Stunting (i.e. poor linear growth) affects one-third of children in developing countries and underlies 14–17% of under-5 mortality (Oloﬁn et
al., 2013). Stunting hinders developmental potential and human capital
due to its long-term impact on cognitive function and economic productivity (Prendergast et al., 2014), and resists current interventions.
Implementing the ten best evidence-based nutrition-speciﬁc interventions at 90% coverage would reduce stunting by only 20%, thereby
achieving only half the World Health Assembly goal of a 40% reduction
by 2025 (Bhutta et al., 2013).
There is increasing recognition that gut structure and function are almost universally abnormal among children living in LMICs. Environmental enteropathy (EE) is an asymptomatic disorder which was
originally described as ‘tropical enteropathy’ (Prendergast and Kelly,
2012; Keusch et al., 2014). The refractoriness of stunting to nutrition-

http://dx.doi.org/10.1016/j.ebiom.2017.07.017
2352-3964/© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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speciﬁc interventions, together with evidence of increased intestinal
permeability related to poor sanitation (Humphrey, 2009), and the impact of enteropathogens (Kosek and the MAL-ED Network Investigators,
2017) suggests that environmental enteropathy contributes to stunting
(Prendergast et al., 2014; Prendergast and Kelly, 2012). Children with
SAM and persistent diarrhea have a severe enteropathy, with very
high burdens of intestinal infection (Amadi et al., 2001; Salazar-Lindo
et al., 2003), enteric inﬂammation (Sullivan et al., 1991), deranged glycosylation (Amadi et al., 2009) and a T-cell activation enteropathy
(Campbell et al., 2003; Veitch et al., 2001).
Among children in LMICs, enteropathy is frequently caused by a
combination of EE, SAM and HIV infection (Prendergast and Kelly,
2012). A precise understanding of the pathology underlying these conditions is lacking because most studies rely on markers of gut injury as
measured in blood and stool, and there have been very few studies informed by small intestinal biopsy. Using confocal laser endomicroscopy
in adults (Kelly et al., 2016), we recently reported that the small intestinal mucosa has increased permeability in EE and that diminished barrier integrity is associated with microbial translocation (Brenchley and
Douek, 2012; Marchetti et al., 2013). However, no studies have yet directly compared gut structure and function in children with SAM to children with only background EE using small intestinal biopsy and noninvasive biomarkers. Furthermore, the contribution of HIV infection to
these enteropathies is unclear.
Here we report a cross-sectional analysis of enteropathy in children
hospitalised with complicated SAM, children from a poor community
with a high prevalence of stunting but without wasting, and adults
from the same community. Its aim was to better understand the pathology of enteropathy in SAM and the contribution, if any, of HIV to its
severity.
2. Methods

samples were collected into EDTA, plain and trace element-free lithium
heparin tubes (Vacutainer, Becton Dickinson; and TekLab respectively).
Blood samples were kept in the dark for 20 min then centrifuged (537g,
15 min). Test solution A contained 1 g L-rhamnose (Sigma, Poole, UK),
5 g lactulose (as lactulose syrup USP) per dose, diluted in water to
100 ml.
The next day, after an overnight fast, urine and blood samples were
collected as above. After 2–3 min of observation and oxygen saturation
recording, intravenous sedation (2.5–10 mg diazepam, 50–100 mg
pethidine) was given and endoscopy performed using Pentax EG2990i
gastroscopes (Pentax, Slough, UK). 2 ml of gastric contents were aspirated from the stomach for pH measurement, and 0.5–3 ml intestinal ﬂuid
was aspirated slowly from the duodenal lumen. Three biopsies were
collected into normal saline, orientated under the dissecting microscope
(Swift Optical Instruments, Schertz, TX at 10× magniﬁcation) in the endoscopy unit, the villus conﬁguration noted, and the biopsies ﬁxed in
formal saline. After 3 h, further blood and urine samples were collected,
and the exact time noted.
2.2. Endoscopy (Children)
Children were evaluated on the day of endoscopy by an experienced
paediatrician (BCA) to conﬁrm ﬁtness for endoscopy, and then fasted
from 0600 after a feed of F100, until 1000, the time of the endoscopy.
Endoscopy was carried out using a Pentax 2490k paediatric gastroscope
(8 mm external diameter) under sedation by an anaesthetist using ketamine-based protocols. Two biopsies were orientated and ﬁxed as above.
Lactase deﬁciency was tested in an additional biopsy for using the Biohit
Lactose Intolerance Quick Test kit (Biohit, Ellesmere Port, UK). Test solution C, for children, contained 0.2 g rhamnose and 1 g lactulose per dose,
made up to 50 ml, and was instilled down the endoscope as previously
described (Kelly et al., 2004).

This study was granted approval by the University of Zambia Biomedical Research Ethics Committee (ref 006-01-13) on 11th April
2013, and was conducted in full compliance with the Declaration of Helsinki. Children hospitalised with SAM in the University Teaching Hospital were enrolled in the study following signed informed caregiver
consent, on the basis that small intestinal biopsy was indicated for malnutrition and persistent diarrhea of unknown aetiology (stool parasitology and culture negative). Persistent diarrhea was deﬁned as 3 or more
loose or watery stools per day for 14 days or more. These children were
all undergoing standard nutritional rehabilitation following WHO
guidelines (Ashworth et al., 2003) so they were all receiving milkbased feeds (F75 and F100). HIV testing, following national guidelines,
was carried out as part of their routine care on the ward, using serology
(Unigold and Determine) and with PCR conﬁrmation for children under
18 months of age. HIV infected children were started on antiretroviral
therapy before discharge from the ward. Adult volunteers were recruited in Misisi, Lusaka, using a 3-stage consent process as previously described (Zulu et al., 2014). Children in the community were identiﬁed
during the course of a community malnutrition screening programme
(Amadi et al., 2016) and caregivers provided written informed consent
to join the study. Adults and children from the community were
screened for recent episodes of diarrhea (one month), NSAID use (one
month), antibiotic use (one month) and excluded and treated if needed.
Thus, 20 adults were excluded because of concurrent illness, pregnancy
or use of antibiotics or NSAIDs, so 61 adults were studied, and of these
41 adults had satisfactory biopsies for morphometry.

2.3. Clinical Procedures (Children in the Community)

2.1. Clinical Procedures - Adults

2.6. Biomarkers

In adult participants, following an overnight fast, blood and urine
samples were collected and then 100 ml of test solution A was given
by mouth. After exactly 3 h, further urine and blood samples were collected. 1 ml of 20% chlorhexidine was added to urine samples. Blood

To estimate the severity of translocation, we measured plasma lipopolysaccharide (LPS) and carried out PCR for bacterial 16S ribosomal
DNA as direct markers of translocation (see Supplementary data),
while serum lipopolysaccharide binding protein (LBP), soluble CD14

Absorption and permeability testing was carried out using a very
similar protocol to that used in adults, except that the period of fasting
was limited to 1 h and that test solution C was taken orally. HIV testing
was not carried out on these children.
2.4. Morphometry
Biopsies were processed, parafﬁn embedded, sectioned into 3 μm
sections and stained with haematoxylin and eosin. Morphometry was
carried out using NanoZoomer Digital Pathology (Hamamatsu Photonics, Hamamatsu, Japan) as previously described (Kelly et al., 2004,
2016) (Supplementary Fig. S1). The following measurements were
made: villus height (VH) and width (VW), crypt depth (CD), villus mucosal perimeter (VP) as a measure of epithelial surface area and related
to length of muscularis mucosae, and villus cross-sectional area (VA) as
a measure of villus volume. VH/CD and villus surface area/volume ratio
(SAVR) (Kelly et al., 2016) were derived from these. Claudin-4 immunostaining was performed on 3 μm sections (see Supplementary material).
2.5. Sugar Analysis
Urine samples were collected at 3 h in adults, and 60 min in children.
Lactulose and rhamnose were assayed by mass spectrometry in urine
samples as previously described (Faubion et al., 2016).
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(sCD14), CD163 and C-reactive protein (CRP) were used as indirect
markers of the host response to translocated bacterial molecules
(Table 2). Quantiﬁcation of LPS was by the Pyrochrome Limulus Amoebocyte Lysate (LAL) assay (Associates of Cape Cod, Liverpool, UK).
Serum LPS binding protein, CRP, sCD14, CD163, IGF-1 and IGFBP3
were measured by ELISA (R&D systems, Abingdon, UK:
RRID:SCR_006140). DNA was isolated from plasma using the QIAamp
DNA Mini Kit (Qiagen: RRID:SCR_008539), according to the
manufacturer's instructions, then analyzed by PCR (see Supplementary
material). Total immunoreactive GLP-2 was measured in fasted serum
by ELISA (Millipore, St Charles, MO: RRID:SCR_008983). Intestinal
FABP was measured by ELISA (Hycult, Cambridge Bioscience, Cambridge, UK: RRID: SCR_002245). Protein was extracted from duodenal
aspirates using a lysis buffer made up of 2-mercaptoethanol and
Laemmli buffer, then Western blots were probed for TFF3 using
mouse monoclonal antibody to TFF3 (Abcam, Cambridge, UK: RRID:
SCR_012931) and detected using VECTASTAIN anti-mouse IgG Biotinylated
antibody
(Vector
laboratories,
Peterborough,
UK:
RRID:SCR_000821). All assays were conducted in duplicate.
2.7. Coeliac Serology
Tissue transglutaminase IgA antibodies were measured in serum
using the Orgentech ELISA kit (Launch Diagnostics, Longﬁeld, UK) and
the Quanta Lite ELISA kit (Inova Diagnostics, San Diego, USA). Antibodies to deamidated gliadin peptides were measured using the Quanta Lite
Gliadin IgGII kit (Inova). The Orgentech ELISAs were run in both the Lusaka and Mayo Clinic laboratories (ρ = 0.88; p b 0.0001); the Inova TTG
and DGP ELISAs were run only in the Mayo Clinic.
2.8. Data Analysis
Data analysis was carried out using Stata 13 (Stata Corp, College Station, TX). Spearman's rank correlation coefﬁcient and the Kruskal-Wallis test were used for hypothesis testing as most variables were not
normally distributed.
2.9. Role of the Funding Source
The funding sources played no role in the decision to publish, data
analysis, or in the drafting of the manuscript. The corresponding author
had free access to all data.
3. Results
We enrolled 34 children with SAM and persistent diarrhea not responsive to standard treatment (Supplementary Table 1). Three of
these children died later during hospitalization. During a programme
of screening for malnutrition in Misisi, 101 children who were not
acutely malnourished were also evaluated (Supplementary Table 1).
Written consent was obtained from caregivers for child participants.
Following a 3-stage recruitment and consent process, 81 unselected
HIV-seropositive and HIV-seronegative adults from Misisi agreed to
participate in the study (Supplementary Table 2).
3.1. Morphological Severity of Enteropathy
Children hospitalised with SAM, and all adults, underwent endoscopy to collect duodenal biopsies. Children from the community did not
have endoscopy. All biopsies were examined immediately after endoscopy using a binocular microscope and all demonstrated evidence of villus morphological change, with ridges and convolutions and absence of
ﬁnger-like villi. This corresponded to histological evidence of villus
blunting and inﬁltration of the mucosa by chronic inﬂammatory cells
(Fig. 1). Villus height (VH), crypt depth (CD), villus width (VW), and
VH:CD ratio were measured satisfactorily in biopsies from 41 adults
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and 22 children; they did not differ signiﬁcantly between adults with
EE and children with SAM, irrespective of HIV status (Table 1). However,
two biopsies from children with SAM showed total villus atrophy (Fig.
1); both these children died during their admission. One other child
died on the ward; this child had partial villus atrophy with a measured
villus height (VH) of 198 μm and a villus height:crypt depth ratio of 1.2.
Overall, the three children who died in hospital had lower VH (median
83 μm; IQR 74–198) than those who survived (216 μm; 175–246; P =
0.04) but crypt depth (CD) did not differ (170 vs 156 μm; P = 0.32).
SAVR was reduced in HIV-infected children with SAM, but otherwise
HIV status had little impact on mucosal morphology (Table 1). Epithelial
breaks (Figs. 1 and 2) were seen in all biopsies from children with SAM
and in 53/54 (98%) of 54 (98%) adults evaluated. The frequency of
breaks was unrelated to villus height, crypt depth or other morphometric parameters (data not shown).
Of 17 children with SAM from whom a biopsy was available for lactase testing, 7 (41%) were lactase deﬁcient (Table 1). Villus height was
markedly reduced in 3 children with lactase deﬁciency whose morphometry data were available (median 83 μm; IQR 74–143) compared
to 8 children without lactase deﬁciency (median 201 μm; IQR 170–
230; P = 0.02).
3.2. Claudin 4 and E-Cadherin Immunostaining
To clarify the signiﬁcance of these breaks, we performed immunostaining for the tight junction protein claudin-4 and the adherens junction protein E-cadherin (Fig. 2). Overall, claudin-4 expression was
reduced in all biopsies, compared to previous experience in healthy tissue (Turner, 2009; Gunzel and Yu, 2013), and E-cadherin immunostaining was disrupted at the sites of epithelial breaks. However, claudin-4
immunostaining was markedly increased and disorganised at the villus
tip and at sites of epithelial breaks (Fig. 2).
3.3. Biomarkers of Mucosal Integrity
Lactulose and rhamnose, measured as percentage excretion of the
oral dose given and as a urinary ratio, were used to measure intestinal
permeability (Faubion et al., 2016). Failed tests occurred in 65% of the
children with SAM and 30% of the children in the community; this
was largely due to inability to pass urine in the 60 min speciﬁed in the
protocol. Lactulose recovery and the lactulose:rhamnose (LR) recovery
ratio were greater in malnourished children than in adults or community children (Table 2). The LR ratio was inversely correlated with villus
surface area in adults and children in whom both morphometric measurements and satisfactory LR measurements were obtained (ρ =
−0.35, P = 0.02; n = 47), but with no other morphometric measurement. Rhamnose recovery was positively associated with villus surface
area:volume ratio (ρ = −0.40, P = 0.005; n = 47) but not with other
morphometric parameters. Intestinal type fatty acid binding protein
(FABP) was increased in all three groups of children, especially children
with SAM, compared to adults (Table 2).
3.4. Markers of Microbial Translocation
Lipopolysaccharide (LPS) concentrations were higher in plasma
which was also positive for bacterial 16S rRNA gene DNA (median
137, IQR 61–257 EU/ml) compared to plasma in which no bacterial
DNA was detected (median 79, IQR 0–191 EU/ml; P = 0.01). Direct
markers of translocation (16S DNA and LPS) were markedly higher in
adults and malnourished children than in healthy children (Table 2). Indirect markers of bacterial translocation (LBP and CD163, markers of the
host response to pathogen associated molecular patterns) were elevated in malnourished children compared to other groups (Table 2). In all
children combined, irrespective of nutritional status, IGF-1 was modestly and inversely correlated with LPS (ρ = −0.23, P = 0.02; n = 100),
consistent with translocation of microbes or their components being
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Fig. 1. Mucosal histology in severe acute malnutrition. A, histological section from a child with severe acute malnutrition (SAM) showing moderate villus blunting (villus height 247 μm). B
shows a higher magniﬁcation of A at the point of the arrow, an early epithelial discontinuity measuring 62.5 μm. C and D, detachment of pale and irregular epithelial cells in biopsies from
two adults with EE; at the site of these more extensive discontinuities or microerosions (black arrows) the basement membrane is exposed to the luminal stream. E, a biopsy from a child
with SAM showing subtotal villus atrophy.

inhibitory for growth hormone axis activity. No such relationships were
detected between IGF-1 and inﬂammatory markers (CRP, sCD14,
CD163).

association was stronger in HIV negative adults (ρ = − 0.51; P =
0.001; n = 37; Fig. 3). In children with SAM, translocation was associated with reduced TFF3: LPS was undetectable in 3 of 4 children with detectable TFF3 dimer in duodenal aspirates (P = 0.03; Fig. 3).

3.5. Mucosal Repair Peptides
3.6. Anti-Tissue Transglutaminase (TTG) and Related Antibodies
We measured two proteins which promote epithelial restitution:
the hormone glucagon-like peptide 2 (GLP-2) (Mutanen and
Pakarinen, 2016) in blood, and trefoil factor 3 (TFF3) (Hoffmann,
2009) in intestinal secretions. Serum GLP-2 concentrations were higher
in children than adults (Table 2), and lower than the reference range
(Mutanen and Pakarinen, 2016) in all our participants. LPS was inversely correlated with GLP-2 (ρ = − 0.35, P = 0.01; n = 54) and this

In view of the extensive structural change seen in some biopsies, and
most notably in two children with subtotal villus atrophy who expired
before discharge, testing for coeliac disease serology was explored in
children with SAM and in adults, even though the therapeutic as well
as the staple diets of children with SAM contain minimal gluten. Tissue
transglutaminase (TTG) IgA antibody concentrations, by two different

Table 1
Morphometry and gastric pH in adults and children.
Measurement

HIV negative SAM (n
= 14)

HIV positive SAM
(n = 8)

HIV negative adults (n = 31)

HIV positive adults (n = 10)

P (all
groups)

Villus height (μm)

211 (164–246)
[74–281]
155 (144–170)
[106–208]
143 (129–166)
[93–501]
467 (367–614)
[132–930]
15,006
(11008–18,111)
[5510–32,179]
1.37 (0.96–1.56)
[0.44–1.89]
0.033 (0.029–0.035)
[0.020–0.040]

206 (180–239)
[83–284]
173 (144–200)
[126–220]
175 (163–247)
[126–524]
426 (407–499)
[139–562]
16,505
(13909–19,363)
[7481–23,604]
1.30 (1.12–1.46)
0.41–1.53]
0.028
(0.021–0.029)
[0.018–0.030]
4.8 (3.0–6.0) n =
10
6/10 (60%)
1/4 (25%)

217 (196–248)
[151–362]
161 (144–174)
[128–218]
171 (147–195)
[103–252]
634 (465–714)
[273–789]
18,726 (16489–25,083)
[13702–31,595]

242 (204–280)
[195–293]
170 (136–195)
[123–208]
189 (145–227)
[116–261]
522 (462–562)
[290–756]
19,371 (14679–21,437)
[13613–25,515]

0.12

1.35 (1.22–1.51)
[0.89–2.25]
0.031 (0.027–0.035)
[0.013–0.044]

1.44 (1.35–1.57)
[1.21–1.84]
0.028 (0.026–0.031)
[0.020–0.034]

0.35

1.5 (1.0–2.5)

4.0 (1.5–5.5)

0.0007

5/35 (14%)
nt

10/21 (48%)
nt

0.05

Crypt depth (μm)
Villus width (μm)
Villus epithelial surface (μm)
Villus cross-sectional area (μm2) per 100 μm
muscularis mucosae
VH:CD
Villus SA:volume ratio

Gastric pH

3.5 (2.0–5.5) n = 15

Hypochlorhydria (fasting pH N 4.0)
Lactase deﬁciency

7/15 (47%)
6/13 (46%)

0.80
0.58
0.005
0.02

0.61

Values given are median with interquartile range in parentheses () and range in brackets []. SAM, severe acute malnutrition; VH, villus height; CD, crypt depth; SA, surface area; nt, not
tested.
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Fig. 2. Epithelial histology and disruption of claudin 4 and E-cadherin. Epithelial breaks imaged in pairs in nearby sections from three children with severe acute malnutrition, each in a
separate column. Top row: haematoxylin/eosin (H&E) stains with scale bar representing 50 μm. Second row, magniﬁed H&E images of boxes from the ﬁrst row with scale bars
representing 20 μm. Third row, images of same sections shown in ﬁrst row, with E-cadherin immunostaining in green, claudin-4 immunostaining in red, and nuclei (DAPI) in blue;
scale bars at 50 μm. Fourth row, further magniﬁcation of boxes from third row, using the same colour code, and scale bars at 20 μm.

ELISAs, were normal in sera from all adults and children, and the results
of both ELISAs correlated closely (ρ = 0.81, P b 0.0001; n = 20). However, anti-TTG antibodies, even within the normal range, were higher
in HIV infected children (median 2.4 U/ml, IQR 2.3–2.7) than in HIV-uninfected children (2.1 U/ml, 2.0–2.2; P = 0.01). This difference was not
seen in adults. IgG anti-deamidated gliadin peptide (DGP) antibodies
were negative in adults, but positive in 3 children, one of whom died
in hospital and one of whom died after discharge. Although TTG IgA
concentrations were within the normal range, the two children who
died in hospital had higher TTG IgA (Inova Quant) concentrations
(0.72 and 1.09 U/ml) than children who survived (median 0.55; IQR
0.52–0.6); this was statistically signiﬁcant (P = 0.04) even though the
number of events was very small. Anti-DGP IgG concentrations were
higher in children with SAM (median 2.7 U/ml, IQR 1.5–8.6) than in
adults (1.6, 1.4–2.1; P = 0.005), and were inversely correlated with villus height (ρ = −0.79, n = 13, P = 0.001; Fig. 4). Anti-DGP IgG concentrations were also higher in children who died (median 55 U/ml; IQR
8.6–102) than in those who did not (2.7; 1.5–5.1; P = 0.04). All three serological tests were strongly correlated with LBP (ρ = 0.71, P = 0.006

for TTG IgA (Orgentech); ρ = 0.83, P b 0.0001 for TTG IgA (Inova; Fig.
4); and ρ = 0.57, P = 0.006 for anti-DGP IgG).
4. Discussion
Children living in LMICs may have one or more enteropathies, with
or without a contribution from HIV infection. Together they are believed
to contribute substantially to child morbidity and mortality. Here we report a comparison of the pathology and severity of enteropathy in children with severe acute malnutrition and well children and adults living
in a community where the prevalence of stunting is high and from
which, historically, many admissions to the hospital malnutrition
ward have originated. Using histopathology and other biomarkers of
enteropathy, we found that the principal difference between these different groups was one of degree: severe malnutrition is associated
with severe enteropathy, intense microbial translocation and severe
systemic inﬂammation. No biopsy was normal: almost all biopsies demonstrated villus remodeling and epithelial breaks with disorganization
of claudin 4 and E-cadherin. The most severe enteropathy (total villus
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Table 2
Biomarkers of microbial translocation and mucosal dysfunction in environmental, HIV and malnutrition enteropathy.
Biomarker

Normal rangea

HIV negative
children with
SAM (n = 20)

HIV positive children
with SAM (n = 14)

HIV negative
adults (n = 39)

HIV positive
adults (n = 22)

Community
children (n = 101)

P

16S rDNA PCR positive
LPS (EU/ml)

Not established
Not established

Not established

4/6 (67%)
120 (0−223)
[0–339]
n=7
253 (170–356)
[159–530] n = 7

sCD14 (mg/l)

0.8–3.2

CD163 (μg/l)

88–902

19/34 (56%)
187 (92–374)
[23–1219]
n = 36
22.9 (19.8,28.5)
[15.1–35.9]
n = 39
1.62 (1.34–1.84)
[0.74–2.46]
n = 39
618 (408–804)
[188–1706]
n = 39

14/20 (70%)
122 (66–202)
[36–536]
n = 22
28.9 (26.6,37.2)
[15.5 = 43.1]
n = 22
1.84 (1.40–2.41)
[0.54–4.24]
n = 22
684 (453–1068)
[50–2605]
n = 22

13/82 (16%)
50.9 (0−111)
[0–869]
n = 108
40.3 (32.9–48.2)
[1.8–82.8]
n = 94
1.78 (1.54–2.14)
[0.80–3.37]
n = 78
874 (686–1305)
[318–2331]
n = 78

b0.0001
0.0001

LBP (ng/ml)

CRP (mg/l)

0–5.0

Median
11.6, IQR 7.0–18.6

IGF-1 (ng/ml)

43–182

IGFBP-3 (μg/ml)

1.53–3.09

nt

nt

Lactulose recovery (% of
administered dose)

Children: median 0.01
(range 0–0.07)
Adults: mean 0.281
(sd 0.014)
Children: median 0.38
(range 0–1.84)
Adults: mean 11.1
(sd 0.4)
Children: median 0.14
(range 0.06–1.00)
Adults: mean 0.026
(sd 0.0001)
Below 10

0.0823
(0.049–0.120)
[0.0147–0.413]
n = 38
1.70 (0.877–2.62)
[0.3–5.66]
n = 38

0.0597
(0.04–0.137)
[0.0009–0.25]
n = 22
1.21 (0.42–1.85)
[0.3.51]
n = 22

2.01 (1.33,3.04)
[0.17–13.2]
n = 74
2.0 (1.5–2.7)
[0–5.4]
n = 75
26.1 (19.4–36.4)
[0–143]
n = 79
1.22 (0.93–1.43)
[0.34–2.53]
n = 76
0.009
(0.002–0.026)
[0–0.299]
n = 76
0.17 (0.03–0.42)
[0.007–1.75]
n = 76

0.0001

GLP-2 (ng/ml)

2.31 (0.64–10.3)
[0.14–21.0]
n = 22
0.64 (0.49–1.4)
[0–3.43]
n = 22
1.0 (0–2.0)
[0–5.3]
n = 22
nt

ns

Not established

0.95 (0.47–2.45)
[0–16.4]
n = 39
0.65 (0.44–0.86)
[0.18–3.2]
n = 39
1.2 (0.8–2.1)
[0–5.4]
n = 39
nt

nt

FABP (ng/ml)

8/14 (57%)
272 (142–600)
[0–2097]
n = 15
150 (148–190)
[135–258]
n = 15
2.53 (2.19–3.31)
[1.10–4.51]
n = 16
1226
(1007–1983)
[425–3860]
n = 16
1.75 (0.63–5.09)
[0.05–21.0]
n = 16
3.14 (2.5–4.8)
[0.38–13.5]
n = 19
1.8 (1.0–2.3)
[0.5–5.1]
n = 14
11.7 (9.8–20.2)
[9.3–39.4]
n = 15
0.89 (0.35–1.67)
[0.23–2.25]
n = 15
0.0287
(0.017–0.083)
[0.002–0.18]
n=8
0.087
(0.072–0.273)
[0.03–1.16]
n=8
0.213
(0.129–0.289)
[0.062–1.070]
n=8
0.54 (0.51–0.59)
[0.48–0.72]
n = 16
2.12 (2.02–2.21)
[1.93–2.84]
n = 16
1.6 (1.4–3.6)
[1.1–12.3]
n = 16

0.055
(0.045–0.072)
[0.014–0.180]
n = 38
0.57 (0.54–0.64)
[0.05–3.66]

0.066
(0.039–0.103)
[0.030–0.50]
n = 20
0.60 (0.55–0.63)
[0.52–0.84]

0.071
(0.037–0.12)
[0–1.289]
n = 76
nt

0.0001

2.30 (2.18–2.46)
[2.10–6.15]

2.23 (2.18–2.36)
[2.06–2.71]

0 (0–0)
0–2.81]

0.0001

1.48 (1.41–2.04)
[1.20–4.60]

1.51 (1.42–1.96)
[1.20–6.58]

nt

0.0007

Rhamnose recovery (% of
dose)

L:R recovery ratio

Anti-TTG IgA (Inova)
(U/ml)
Anti-TTG IgA (Orgentech)
(U/ml)

Below 10

Anti-DGP IgG (U/ml)

Below 30

2.84 (1.50–3.72)
[1.04–5.49]
n=7
1482 (661–3147)
[551–3441]
n=7
3.67 (0.50–10.31)
[0.46–21.0] n = 7
4.52 (2.76–13.47)
[2.66–15.8] n = 7
4.1 (2.2–5.6)
[0.4–7.6]
n=7
9.3 (9.3–10.1)
[9.3–12.7]
n=6
0.70 (0.49–0.89)
[0–1.34]
n=6
0.10 (0.017–0.474)
[0.015–0.78]
n=4
0.15 (0.068–0.46)
[0.03–0.72]
n=4
0.762 (0.357–1.00)
[0.148–1.05]
n=4
0.61 (0.56–1.09)
[0.54–1.99]
n=7
2.44 (2.30–2.68)
[2.22–2.87]
n=4
15.7 (4.0–45.7)
[2.4–102.2]
n=7

0.0001

0.0001

0.0001

0.0007

0.0001

0.02

0.0001

0.0001

0.02

P is the result of Kruskal-Wallis test or Fisher's exact test across all groups. n is shown where it is less than the number of participants shown at the head of the column. nt, not tested; ns, not
signiﬁcant. LPS, lipopolysaccharide; LBP, LPS binding protein; sCD14, soluble cluster of differentiation 14; CD163, cluster of differentiation 163; CRP, C-reactive protein; FABP, fatty acid
binding protein; GLP-2, glucagon-like peptide 2; IGF-1, insulin-like growth factor-1; IGFBP-3, IGF binding protein-3; TTG, tissue transglutaminase; DGP, deamidated gliadin peptides.
a
Reference ranges are obtained from package inserts in ELISA kits, except for: mono- and disaccharide excretion in children (Faubion et al., 2016), mono- and disaccharide excretion in
adults (Menzies et al., 1999); GLP-2 (Hoffmann, 2009); normal values for some molecules are not established. In the study by Menzies et al. (1999) a 5-hour collection was used so recoveries would be expected to be higher; the LR ratio remains unchanged over 3 or 5 h.

atrophy) was associated with subsequent death in both children in
whom it was found. Children with malnutrition and persistent diarrhea
had the most abnormal markers of microbial translocation and inﬂammation. However, the severity of the villus blunting did not explain
the translocation observed, as the differences in translocation and inﬂammation greatly outweighed the modest morphometric differences.
A comparison of our data with previous morphometric studies is provided in Supplementary material. We readily acknowledge the difﬁculties of interpretation imposed by being unable to justify (ethically)
taking biopsies from apparently healthy children with presumed environmental enteropathy. Our understanding would be greatly enhanced
if well-orientated biopsy material from healthy children were available
for formal morphometric analysis.

Microbial translocation is the passive movement of gut microbes
from the lumen of the intestine into lymphatics, portal blood and thence
into the central circulation (Brenchley and Douek, 2012; Marchetti et al.,
2013). It appears to be a central derangement in the enteropathy of
SAM, with extraordinarily high concentrations of both direct and indirect markers of translocation in blood. Translocation markers were associated with reduced circulating IGF-1 concentrations in children,
consistent with the hypothesis that microbial translocation adversely
affects child growth. The biomarkers of translocation that we measured
could be the degradation products of whole bacteria which cross the
mucosa, or they could reﬂect the translocation of only constituent molecules such as LPS and DNA; both of these act as ligands for pattern recognition receptors (Wells et al., 2017).
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Fig. 3. Molecules protective against microbial translocation. (A) GLP-2 in adults was
negatively associated with circulating lipopolysaccharide (LPS; ρ = −0.35; P = 0.01 in
the whole group, but in HIV seronegatives the correlation was stronger (ρ = −0.51; P
= 0.001). (B) Presence of TFF3 immunoreactivity in duodenal aspirates of children was
associated with greatly reduced circulating LPS (P = 0.03).

Having found very severe mucosal damage in two children with
SAM, we were concerned to exclude coeliac disease, and conducted
three different assays for coeliac disease serology in two laboratories
in Zambia and the USA. While the great majority of these serological results were within the normal range, closer scrutiny revealed that in children with severe acute malnutrition, concentrations of antibodies to
tissue transglutaminase and deamidated gliadin peptides were very
strongly correlated with LBP (a marker of the host response to bacterial
translocation), inversely correlated with villus height, and were highest
in the children who subsequently died. We postulate that in the presence of mucosal T cell activation (Campbell et al., 2003; Veitch et al.,
2001) and epithelial leakiness the cells of the lamina propria can generate autoantibodies, and that this autoreactivity exacerbates mucosal pathology. Autoantibody generation has been reported in Crohn's disease
(Ribeiro-Cabral et al., 2011) and in olmesartan-induced enteropathy
(Esteve et al., 2016) where it was reversible. Exposure to gluten and gliadin peptides is thought to be essential for development of the autoantibodies which characterize coeliac disease (Sollid and Jabri, 2013), but
in Zambia the staple diet is maize, and children being treated for SAM
have a therapeutic feed which includes no gluten (Ashworth et al.,
2003). We have previously reported that elemental feeds enhance
weight gain during nutritional rehabilitation in children with SAM37
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Fig. 4. Coeliac type antibodies. Anti-deamidated gliadin peptides (DGP) and anti-tissue
transglutaminase (TTG) antibodies in children. (A) Correlation between anti-DGP
antibody concentration in serum and villus height (ρ = −0.79; P b 0.0001); two points
with anti-DGP concentrations above 40 U/ml omitted for clarity. (B) Correlation
between anti-TTG antibody concentration (Inova system) in serum and circulating
lipopolysaccharide binding protein, LBP (ρ = 0.83; P b 0.0001).

(Amadi et al., 2005). These serological data suggest that coeliac
antibodies, even within the clinically normal range, may be a useful biomarker of the severity of enteropathy; further work is needed in other
settings to conﬁrm or reﬁne this hypothesis. It does not mean that
these children have coeliac disease: the concentrations were within
the normal range, the children were exposed to minimal gluten. There
are few data on the prevalence of those HLA alleles which mediate
coeliac disease in Africa (Kang et al., 2013). We have considered whether the increased anti-TTG and anti-DGP antibodies may be due to
hypergammaglobulinaemia. There is good evidence that IgA concentrations are increased in SAM, particularly in the presence of oedema
(Rytter et al., 2014). Unfortunately, insufﬁcient serum was available to
measure total immunoglobulins, as blood sampling volumes from
these children are limited. The consistency between IgA anti-TTG and
IgG anti-DGP suggests that this is not merely a reﬂection of increased
circulating IgA concentrations, and we observed no correlation between
severity of edema and antibody concentrations (data not shown).
Claudin-4 is a structural protein of the tight junction that augments
epithelial barrier function in vitro (Turner, 2009; Gunzel and Yu, 2013)
and has been characterized in vivo as a paracellular anion channel (Hou
et al., 2010). Maintenance of tight junctions requires the physical apposition of adjacent cells which are held together, in part, by adherens
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junctions. The principal adherens junction adhesive protein E-cadherin
also interacts with β-catenin to regulate Wnt signaling protein, thereby
allowing loss of intercellular adhesion to promote the proliferation that
is ultimately required for repair. Our data suggest marked disruption of
tight junction distribution. This would be sufﬁcient to explain the increased permeation of lactulose, but insufﬁcient to explain the translocation of intact bacteria, if that is indeed how microbial translocation occurs.
‘HIV enteropathy’ was used at one time to describe the severe diarrhea-wasting syndrome which was so prominent in the early days of
the HIV epidemic, particularly a severe pathogen-negative diarrheamalabsorption syndrome. In populations where EE is also prevalent,
HIV enteropathy is difﬁcult to recognize as it is morphologically indistinguishable from EE apart from an increase in crypt depth, which we
previously reported only in patients with advanced immunosuppression (Kelly et al., 2004). Here we report that villus surface area: volume
ratio was 10% reduced in HIV infection, but no other parameters differed. HIV infection was not associated with an increased level of LPS
or an increased detection of bacterial DNA in either adults or children,
but it was associated with considerably increased CRP.
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